It may be a “tall order,” but Richard Moscicki is spearheading a continued push by FDA to recruit industry officials and academics for vacant executive leadership positions.
Despite some recent high-profile quick departures of senior leaders with predominantly industry backgrounds, Moscicki, the deputy Center for Drug Evaluation and Research director for science operations who himself joined the agency from industry, told
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on Pink Sheet for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?